Voyager Therapeutics is trading at $2.18, up 6.34%, with biotech-sector strength the clearest available context for the move.

  • The supplied market context reports the biotech sector rising about 2.1%; major indexes were mixed.
  • No new company-specific announcement explaining the October 20 move was found, and Voyager’s press-release page showed no news stories available.
  • Trading volume information was unavailable.